Introduction: Who Should Undergo Diagnostics

Vaginal cancer is an uncommon condition that affects only about 1 in 100,000 women, representing just 1 to 2% of all gynecologic cancers^[2]. Because it is so rare and often develops without causing noticeable symptoms, many people may not know they have it until a healthcare provider discovers abnormal cells during a routine checkup^[15]. This is precisely why regular screenings are so important, even when you feel completely healthy.

Women should consider seeking diagnostic evaluations if they experience any unusual symptoms, such as vaginal bleeding that occurs outside of normal menstrual periods, bleeding after sexual intercourse, or bleeding after menopause^[1]. Other warning signs include unusual vaginal discharge, discovering a lump or mass in the vagina, pain during sex, painful urination, frequent urination, constipation, or pelvic pain^[1][12]. Any of these symptoms warrant a visit to a healthcare provider, though it’s important to remember that many of these signs can also be caused by other, less serious health issues.

Certain groups of women face higher risks and should be particularly vigilant about diagnostic screenings. Women over 60 years old are at the greatest risk, as vaginal cancer becomes more common with age^[2]. Those who have been infected with human papillomavirus (HPV), especially high-risk types, should also undergo regular evaluations, as this virus is strongly linked to vaginal cancer^[2]. Women who have previously been diagnosed with cervical cancer or have abnormal cervical cells should be monitored closely, as their risk of developing vaginal cancer is elevated^[2].

Even without symptoms, regular pelvic examinations and Pap smears (also called Pap tests) are essential preventive measures. These routine screenings can detect vaginal cancer at its earliest stages, when it is most treatable^[15]. Many cases of vaginal cancer are discovered during these routine checkups, highlighting the importance of keeping up with scheduled gynecologic appointments^[5].

Diagnostic Methods

When vaginal cancer is suspected, healthcare providers use several diagnostic techniques to confirm the presence of cancer, determine its type, and understand how far it has spread. The diagnostic process typically begins with simpler examinations and may progress to more detailed tests if abnormalities are found.

Pelvic Examination

A pelvic exam is usually the first step in diagnosing vaginal cancer. This examination is often performed during a routine checkup or when a woman reports concerning symptoms^[11]. During this exam, a healthcare professional carefully inspects the outer genitals for any visible abnormalities. The examiner then inserts one or two gloved fingers into the vagina while pressing down on the abdomen with the other hand to feel the uterus, ovaries, and other pelvic organs^[11].

A medical instrument called a speculum is inserted into the vagina to open the vaginal canal, allowing the healthcare provider to visually inspect the vagina and cervix for any changes that could indicate cancer or other problems^[11][8]. This simple examination can reveal lumps, unusual tissue growth, or other abnormalities that require further investigation.

Pap Test (Papanicolaou Smear)

A Pap test, also known as a Pap smear, is commonly performed during a pelvic examination. This test involves collecting cells from the cervix and sometimes the vagina to examine them under a microscope^[8]. While the Pap test is primarily designed to detect cervical cancer, it can sometimes identify abnormal cells that originated in the vagina^[6]. Regular Pap testing is one of the most effective ways to detect vaginal cancer early, before symptoms develop.

Colposcopy

If a pelvic exam or Pap test reveals suspicious changes, the next step is often a colposcopy. This procedure uses a special lighted magnifying instrument called a colposcope to get a detailed, close-up view of the vagina and cervix^[11][12]. The colposcope itself does not enter the vagina; instead, it remains outside the body while a speculum holds the vaginal walls open. The magnification allows the healthcare provider to see abnormal areas that might not be visible to the naked eye during a standard pelvic exam.

Biopsy

A biopsy is the definitive method for diagnosing vaginal cancer. This procedure involves removing a small sample of tissue from the suspicious area to test it for cancer cells^[11]. A biopsy is often performed during a pelvic exam or colposcopy when the healthcare provider identifies an abnormal area. The tissue sample is then sent to a laboratory where specialists examine it under a microscope to determine whether cancer cells are present and, if so, what type of cancer it is^[8].

The biopsy is the only test that can confirm with certainty whether abnormal cells are cancerous. Other tests can suggest the presence of cancer, but only a biopsy can provide a definitive diagnosis.

Imaging Tests

Once vaginal cancer is diagnosed, additional tests may be needed to determine the size of the cancer and whether it has spread to other parts of the body. This process is called staging. Various imaging techniques help doctors understand the extent of the disease.

Computed tomography (CT) scans use X-rays taken from different angles to create detailed cross-sectional images of the body^[11]. These scans can show whether the cancer has spread to nearby lymph nodes, the pelvis, or more distant organs like the lungs or liver.

Magnetic resonance imaging (MRI) uses powerful magnets and radio waves to produce detailed images of soft tissues in the body^[11]. MRI scans are particularly useful for examining the pelvis and can help doctors see how deeply the cancer has invaded surrounding tissues.

Positron emission tomography (PET) scans involve injecting a small amount of radioactive sugar into the bloodstream. Cancer cells, which use more energy than normal cells, absorb more of this sugar and appear brighter on the scan^[11]. PET scans can help identify cancer that has spread to distant parts of the body.

Chest X-rays may be performed to check whether vaginal cancer has spread to the lungs, as this is one of the more common sites for distant spread^[16].

Additional Examinations

In some cases, doctors may need to examine other organs to determine if cancer has spread. Cystoscopy is a procedure that uses a thin tube with a camera to look inside the bladder and urethra (the tube that carries urine out of the body)^[12]. This test checks whether cancer has spread to these structures.

Proctoscopy or sigmoidoscopy examines the rectum and lower part of the colon using a similar tube with a camera. These tests can reveal if cancer has invaded the rectum or surrounding areas.

Diagnostics for Clinical Trial Qualification

Women who are considering participating in clinical trials for vaginal cancer must meet specific diagnostic criteria to ensure they are suitable candidates. Clinical trials are research studies that test new treatments or treatment combinations to determine their safety and effectiveness. Because these studies follow strict protocols, participants must undergo thorough diagnostic evaluations before enrollment.

The standard diagnostic requirements for clinical trial participation typically include a confirmed diagnosis of vaginal cancer through biopsy. The biopsy not only confirms the presence of cancer but also identifies the specific type, such as squamous cell carcinoma or adenocarcinoma^[12]. This information is crucial because different types of vaginal cancer may respond differently to various treatments.

Staging information is essential for most clinical trials. Researchers need to know the exact size of the tumor, whether it has spread to nearby tissues, and if it has metastasized to distant organs. This requires comprehensive imaging studies, including CT scans, MRI, and sometimes PET scans^[11]. The staging process helps researchers match patients to trials that are testing treatments for their specific stage of disease.

Blood tests are commonly required before enrollment in clinical trials. These tests assess overall health and organ function, particularly of the liver and kidneys, which process many cancer treatments. Blood counts are checked to ensure the bone marrow is producing enough healthy blood cells. These baseline measurements also provide comparison points to monitor how well a patient tolerates the experimental treatment during the trial.

Many trials require tests to determine the presence of HPV and, in some cases, the specific strain of the virus. Since HPV is strongly associated with vaginal cancer, particularly squamous cell carcinoma, this information can be important for selecting appropriate treatments and understanding how the cancer might respond^[2][16].

Performance status assessments measure how well a patient can perform daily activities. These evaluations help determine whether someone is strong enough to participate in a trial and tolerate the experimental treatment. Doctors use standardized scales to rate a patient’s ability to care for themselves and carry out normal activities.

Some clinical trials may require additional specialized tests depending on the treatment being studied. For example, trials testing immunotherapy drugs may require tests to measure specific proteins or markers on cancer cells. Trials evaluating targeted therapies may need genetic or molecular testing of the tumor to identify specific mutations or characteristics that the treatment is designed to address.

Women interested in clinical trials should discuss the diagnostic requirements with their healthcare team. Understanding what tests are needed can help patients prepare for the enrollment process and make informed decisions about whether a particular trial is right for them.